Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel semi-synthetic method for Paclitaxel and Docetaxel via stereochemical inversion. High-yield, scalable process for reliable pharmaceutical intermediate supply.
Novel semi-synthesis of paclitaxel and docetaxel using trans-chiral side chains and stereochemical inversion. High yield, industrial scale potential.
Patent CN1829722A details a regioselective boronate route for CCI-779, eliminating chromatography for cost-effective API intermediate manufacturing.
Patent CN102276615A reveals a high-yield total synthesis of (-)-5-N-formalardeemin. Discover cost-effective manufacturing strategies for this potent MDR reversal agent.
Patent CN102838586A details a mild condensation and reduction route for Lenalidomide, offering >99.9% purity and simplified workup for reliable pharmaceutical intermediate supply chains.
Patent CN101193866A details a safer, chromatography-free synthesis route for kinase inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103044467A details a scalable route for R-(1-amino-3-methyl)butyl pinacol borate, eliminating cryogenic conditions and column chromatography for cost-effective manufacturing.
Patent CN109928975B reveals a novel Ribociclib synthesis route eliminating noble metals. Discover cost-effective manufacturing and supply chain advantages for CDK4/6 inhibitors.
Novel low-temperature process achieves 99.3% purity. Reduces waste and avoids carcinogenic solvents. Ideal for API manufacturing cost reduction.
Advanced patent CN113816962A reveals novel catalytic routes for Btk inhibitors. Discover cost-effective manufacturing strategies and high-purity supply chain solutions for global pharma.
Patent CN106565707A reveals a novel Palbociclib synthetic route eliminating noble metals. Discover cost reduction in API manufacturing and high-purity supply chain solutions.
Patent CN112930348A details an enzymatic route for Safraninib, improving yield and reducing waste compared to chiral resolution methods.
Patent CN101274923B reveals a novel nitrate-catalyzed method for selective acylation, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112250611B reveals a novel Friedel-Crafts route for Larotrectinib intermediates. Achieve high purity and cost reduction in API manufacturing with scalable chemistry.
Advanced synthesis of low-cardiotoxicity anthracycline intermediates via novel reductive amination. Optimized for scale-up and purity in API manufacturing.
Novel preparation method of Neratinib avoiding toxic chlorination. Cost-effective, scalable API intermediate manufacturing process for pharmaceutical supply chains.
Patent CN103288804A reveals a streamlined one-step condensation for Nilotinib, offering superior atom economy and simplified supply chains for API manufacturers.
Novel semi-synthetic process for taxane derivatives using activated oxazoles. Offers improved yield and purity for API manufacturing.
Patent CN112174970B reveals a scalable method for Pemetrexed Disodium using alkali-modified molecular sieves, ensuring high yield and reduced environmental impact.
Patent CN113024521B reveals a streamlined 5-step synthesis for Entrectinib, offering high purity and mild conditions for reliable API intermediate supply chains.